Growth Metrics

Addentax (ATXG) Cash & Equivalents (2016 - 2025)

Addentax has reported Cash & Equivalents over the past 11 years, most recently at $238466.0 for Q4 2025.

  • Quarterly Cash & Equivalents fell 50.33% to $238466.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $238466.0 through Dec 2025, down 50.33% year-over-year, with the annual reading at $324953.0 for FY2025, 60.19% down from the prior year.
  • Cash & Equivalents was $238466.0 for Q4 2025 at Addentax, down from $445726.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.2 million in Q2 2022 and troughed at $238466.0 in Q4 2025.
  • The 5-year median for Cash & Equivalents is $760607.0 (2021), against an average of $954167.3.
  • Year-over-year, Cash & Equivalents skyrocketed 247.03% in 2021 and then plummeted 78.17% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $506342.0 in 2021, then surged by 213.7% to $1.6 million in 2022, then crashed by 68.63% to $498254.0 in 2023, then decreased by 3.65% to $480082.0 in 2024, then plummeted by 50.33% to $238466.0 in 2025.
  • Per Business Quant, the three most recent readings for ATXG's Cash & Equivalents are $238466.0 (Q4 2025), $445726.0 (Q3 2025), and $490716.0 (Q2 2025).